Zimmer Biomet Holdings, Inc. - Mar 1, 2022 Form 4 Insider Report for ZimVie Inc. (ZIMV)

Role
10%+ Owner
Signature
/s/ Chad Phipps, Senior Vice President, General Counsel and Secretary
Stock symbol
ZIMV
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/1/2022, 03:48 PM
Previous filing
Feb 7, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZIMV Common Stock Other $0 -20.9M -80.3% $0.00 5.13M Mar 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 7, 2022, Zimmer Biomet Holdings, Inc., a Delaware corporation ("Zimmer Biomet"), reported that it owned 100 shares of common stock of ZimVie Inc., a Delaware corporation ("ZimVie"), which at the time constituted all of the issued and outstanding shares of common stock of ZimVie. On February 28, 2022, pursuant to the Amended and Restated Certificate of Incorporation of ZimVie filed by ZimVie with the Secretary of State of the State of Delaware on such date, the 100 outstanding shares of common stock of ZimVie held by Zimmer Biomet were automatically converted into an aggregate of 26,050,488 fully-paid and nonassessable shares of common stock of ZimVie.
F2 On March 1, 2022, 20,918,542 shares of common stock of ZimVie were distributed by Zimmer Biomet by way of a pro rata dividend to its stockholders. Zimmer Biomet has retained the remaining 5,131,946 shares of common stock of ZimVie.